SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001410578-24-000954
Filing Date
2024-05-23
Accepted
2024-05-23 16:09:23
Documents
74
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 6-K cvac-20240331x6k.htm   iXBRL 6-K 91226
2 EX-99.1 cvac-20240331xex99d1.htm   iXBRL EX-99.1 626572
3 EX-99.2 cvac-20240331xex99d2.htm EX-99.2 230109
4 GRAPHIC cvac-20240331xex99d1001.jpg GRAPHIC 9809
  Complete submission text file 0001410578-24-000954.txt   4457183

Data Files

Seq Description Document Type Size
5 EX-101.SCH cvac-20240331.xsd EX-101.SCH 61616
6 EX-101.CAL cvac-20240331_cal.xml EX-101.CAL 55308
7 EX-101.DEF cvac-20240331_def.xml EX-101.DEF 191828
8 EX-101.LAB cvac-20240331_lab.xml EX-101.LAB 371782
9 EX-101.PRE cvac-20240331_pre.xml EX-101.PRE 293105
78 EXTRACTED XBRL INSTANCE DOCUMENT cvac-20240331x6k_htm.xml XML 615760
Mailing Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076
Business Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076 49 7071 9883 0
CureVac N.V. (Filer) CIK: 0001809122 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39446 | Film No.: 24978266
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)